Given the compelling evidence and the ongoing clinical trials, incorporating GLP-1 RAs as adjuncts to insulin therapy in adults and adolescents with T1D could provide significant clinical benefits. The gene discussed is GCG; the disease is type 1 diabetes mellitus.